Literature DB >> 9256843

Proxies' decisions about clinical research participation for their charges.

H L Muncie1, J Magaziner, J R Hebel, J W Warren.   

Abstract

OBJECTIVE: To examine the process by which proxies decide about their charges' participation in clinical research.
DESIGN: Using eight hypothetical research studies encompassing a variety of risks and benefits, we interviewed 315 competent persons > or = 65 years old (charges) and, separately, the individuals who would be designated as their proxies if the charges were to become incompetent. The proxies were asked what they thought their charges would decide and what decisions they would make for their charges and for their own participation. SETTINGS: A medical house-call program, two apartment complexes, and three nursing homes. PARTICIPANTS: Charges > or = 65 years old and their proxies. MAIN OUTCOME MEASURE: Comparison of decisions made by charges and by proxies for their charges.
RESULTS: The agreement between the proxies' and charges' decisions was not significantly different from random agreement (range of kappa statistics, 0.05-0.15). Rather, proxies' decisions for their charges were significantly related to the proxies' decisions for themselves (kappas, 0.52-0.86). When the paired proxies' and charges' decisions differed, the proxies were protective, more frequently refusing their charges' participation in the perceived riskier research studies.
CONCLUSIONS: Proxies did not know what their charges would decide. Their choices for the charges related more to the proxies' decisions about their own participation (which they knew) than to the decisions of their charges (which they didn't know). This is similar to the process of a reasonable person making the decision, a characteristic of decisions made in the best interests of the patient.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  1997        PMID: 9256843     DOI: 10.1111/j.1532-5415.1997.tb02961.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  8 in total

Review 1.  The ethics of informed consent in Alzheimer disease research.

Authors:  Scott Y H Kim
Journal:  Nat Rev Neurol       Date:  2011-05-24       Impact factor: 42.937

2.  "Thinking about it for somebody else": Alzheimer's disease research and proxy decision makers' translation of ethical principles into practice.

Authors:  Laura B Dunn; Stephanie Reyes Fisher; Melinda Hantke; Paul S Appelbaum; Daniel Dohan; Jenifer P Young; Laura Weiss Roberts
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

Review 3.  Research ethics issues in geriatric psychiatry.

Authors:  Laura B Dunn; Sahana Misra
Journal:  Psychiatr Clin North Am       Date:  2009-06

4.  Can response-adaptive randomization increase participation in acute stroke trials?

Authors:  Jason S Tehranisa; William J Meurer
Journal:  Stroke       Date:  2014-06-10       Impact factor: 7.914

5.  Using data to improve surrogate consent for clinical research with incapacitated adults.

Authors:  Emily Abdoler; David Wendler
Journal:  J Empir Res Hum Res Ethics       Date:  2012-04       Impact factor: 1.742

6.  Patients' preferences for enrolment into critical-care trials.

Authors:  Damon C Scales; Orla M Smith; Ruxandra Pinto; Kali A Barrett; Jan O Friedrich; Neil M Lazar; Deborah J Cook; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2009-06-24       Impact factor: 17.440

7.  Promoting advance planning for health care and research among older adults: a randomized controlled trial.

Authors:  Gina Bravo; Marcel Arcand; Danièle Blanchette; Anne-Marie Boire-Lavigne; Marie-France Dubois; Maryse Guay; Paule Hottin; Julie Lane; Judith Lauzon; Suzanne Bellemare
Journal:  BMC Med Ethics       Date:  2012-01-05       Impact factor: 2.652

8.  The accuracy of surrogate decision makers: informed consent in hypothetical acute stroke scenarios.

Authors:  Jessica Bryant; Lesli E Skolarus; Barbara Smith; Eric E Adelman; William J Meurer
Journal:  BMC Emerg Med       Date:  2013-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.